Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Change in Account Payables (2021 - 2025)

Entera Bio has reported Change in Account Payables over the past 5 years, most recently at $232000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables rose 546.15% year-over-year to $232000.0, compared with a TTM value of $316000.0 through Dec 2025, up 544.9%, and an annual FY2025 reading of $316000.0, up 544.9% over the prior year.
  • Change in Account Payables came in at $232000.0 for Q4 2025, up from -$167000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $324000.0 in Q3 2023 to a low of -$481000.0 in Q4 2023.
  • Median Change in Account Payables over the past 5 years was $18000.0 (2022), compared with a mean of $14200.0.
  • The largest YoY upside for Change in Account Payables was 8200.0% in 2025 against a maximum downside of 245.22% in 2025.
  • Over 5 years, Change in Account Payables stood at -$159000.0 in 2021, then crashed by 149.06% to -$396000.0 in 2022, then fell by 21.46% to -$481000.0 in 2023, then surged by 89.19% to -$52000.0 in 2024, then skyrocketed by 546.15% to $232000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Change in Account Payables are $232000.0 (Q4 2025), -$167000.0 (Q3 2025), and $249000.0 (Q2 2025).